Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies - Narratives (Details)

v3.25.3
Significant Accounting Policies - Narratives (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Apr. 11, 2025
$ / shares
Sep. 30, 2025
USD ($)
customer
$ / shares
Sep. 30, 2024
USD ($)
customer
Sep. 30, 2025
USD ($)
customer
$ / shares
Sep. 30, 2024
USD ($)
customer
Dec. 31, 2024
$ / shares
Concentration Risk            
Number of customers (customer) | customer   5 5      
TOTAL OPERATING REVENUE   $ 345,253 $ 362,124 $ 1,074,266 $ 1,129,769  
Scenario, Adjustment            
Concentration Risk            
Interest Expense, Operating   6,900   4,700    
Capitated Revenue [Member]            
Concentration Risk            
TOTAL OPERATING REVENUE   $ 341,555 $ 357,706 $ 1,062,796 $ 1,116,146  
Class A Common Stock            
Concentration Risk            
Reverse stock split (percent) 0.02          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001   $ 0.0001   $ 0.0001
Class V Common Stock            
Concentration Risk            
Reverse stock split (percent) 0.02          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001   $ 0.0001   $ 0.0001
Four Health Plan Customer | Revenue | Customer Concentration            
Concentration Risk            
Percentage of total revenue (as a percent)   76.00% 69.00% 75.00% 59.00%  
Five Health Plan Customer [Member] | Revenue | Customer Concentration            
Concentration Risk            
Number of customers (customer) | customer       5 4